---
figid: PMC4943290__JAH3-5-e003440-g001
figtitle: Agents acting on the renin–angiotensin system pathway ©PharmGKB
organisms:
- Homo sapiens
- Citrus x paradisi
- Osphranter robustus
pmcid: PMC4943290
filename: JAH3-5-e003440-g001.jpg
figlink: /pmc/articles/PMC4943290/figure/jah31449-fig-0001/
number: F1
caption: Agents acting on the renin–angiotensin system pathway ©PharmGKB. Reproduced
  with permission from the Pharmacogenomics Knowledge Base (PharmGKB) and Stanford
  University (https://www.pharmgkb.org/pathway/PA165110622#PGG). ACE indicates angiotensin‐converting
  enzyme; AGT, angiotensinogen; AGTR1, angiotensin II receptor type 1; AGTR2, angiotensin
  II receptor type 2; Ang, angiotensin; ARB, angiotensin receptor blocker; ATP6AP2,
  ATPase H+ transporting accessory protein 2; BDKRB1, bradykinin receptor B1; BDKRB2,
  bradykinin receptor B2; CMA1, chymase 1; CTSG, cathepsin G; CYP11B2, cytochrome
  P450 family 11 subfamily B member 2; KNG, kininogen; MAPK1, mitogen‐activated protein
  kinase 1; MAPK3, mitogen‐activated protein kinase 3; MAS1, MAS1 proto‐oncogene;
  MME, membrane metallo‐endopeptidase; NOS3, nitric oxide synthase 3; NR3C2, nuclear
  receptor subfamily 3 group C member 2; PK, pharmacokinetic; REN, renin; TGFB1, transforming
  growth factor β1.
papertitle: 'Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness
  in Stable Coronary Artery Disease: When Are We Ready to Implement?.'
reftext: Jasmine A. Luzum, et al. J Am Heart Assoc. 2016 Mar;5(3):e003440.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.952759
figid_alias: PMC4943290__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4943290__F1
ndex: e24a2a11-def0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4943290__JAH3-5-e003440-g001.html
  '@type': Dataset
  description: Agents acting on the renin–angiotensin system pathway ©PharmGKB. Reproduced
    with permission from the Pharmacogenomics Knowledge Base (PharmGKB) and Stanford
    University (https://www.pharmgkb.org/pathway/PA165110622#PGG). ACE indicates angiotensin‐converting
    enzyme; AGT, angiotensinogen; AGTR1, angiotensin II receptor type 1; AGTR2, angiotensin
    II receptor type 2; Ang, angiotensin; ARB, angiotensin receptor blocker; ATP6AP2,
    ATPase H+ transporting accessory protein 2; BDKRB1, bradykinin receptor B1; BDKRB2,
    bradykinin receptor B2; CMA1, chymase 1; CTSG, cathepsin G; CYP11B2, cytochrome
    P450 family 11 subfamily B member 2; KNG, kininogen; MAPK1, mitogen‐activated
    protein kinase 1; MAPK3, mitogen‐activated protein kinase 3; MAS1, MAS1 proto‐oncogene;
    MME, membrane metallo‐endopeptidase; NOS3, nitric oxide synthase 3; NR3C2, nuclear
    receptor subfamily 3 group C member 2; PK, pharmacokinetic; REN, renin; TGFB1,
    transforming growth factor β1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACE
  - AGT
  - AGXT
  - REN
  - KCTD11
  - KNG1
  - ACE2
  - ANGPTL3
  - ANGPT1
  - TM7SF2
  - ANGPT4
  - VPS51
  - ANGPTL1
  - ANGPT2
  - CTSG
  - MME
  - MMP12
  - CMA1
  - MAS1
  - PMPCB
  - AGTR2
  - AGTR1
  - BDKRB1
  - ATP6AP2
  - BDKRB2
  - MAPK1
  - NOS3
  - NANOS3
  - TGFB1
  - NR3C2
  - Aldosterone
  - Bradykinin
  - Spironolactone
---
